PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+2.78%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$809M
AUM Growth
+$809M
(-29%)
Cap. Flow
-$228M
Cap. Flow
% of AUM
-28.17%
Top 10 Holdings %
Top 10 Hldgs %
58.32%
Holding
147
New
42
Increased
27
Reduced
25
Closed
33
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$26.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$24.4M |
| 3 |
MacroGenics
MGNX
|
$19.7M |
| 4 |
AbbVie
ABBV
|
$18.5M |
| 5 |
MannKind Corp
MNKD
|
$18.3M |
Top Sells
| 1 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$133M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$69.5M |
| 3 |
Gilead Sciences
GILD
|
$61.2M |
| 4 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$25.8M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$21.8M |
Sector Composition
| 1 | Healthcare | 87.52% |
| 2 | Consumer Discretionary | 0.05% |
| 3 | Industrials | 0.03% |
| 4 | Consumer Staples | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHTP
26
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $7.54M | 0.91% | 1,701,639 -1,716,726 | -50% | -$7.6M |
|
27
Travere Therapeutics
TVTX
$1.56B
| $7.37M | 0.88% | +1,052,692 | New | +$7.37M |
|
|
CTIC
28
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $7.13M | 0.86% | 3,715,000 -3,279,673 | -47% | -$6.3M |
|
|
GENT
29
DELISTED
GENTIUM SPA ADS
GENT
| $6.85M | 0.82% | +120,000 | New | +$6.85M |
|
30
CVS Health
CVS
$92.8B
| $6.39M | 0.77% | 89,330 +87,030 | +3,784% | +$6.23M |
|
|
ZLTQ
31
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $5.78M | 0.69% | 305,593 +291,890 | +2,130% | +$5.52M |
|
|
TARO
32
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $5.6M | 0.67% | +56,602 | New | +$5.6M |
|
|
AERI
33
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.39M | 0.65% | +300,000 | New | +$5.39M |
|
|
GRCE
34
Grace Therapeutics, Inc. Common Stock
GRCE
$41.9M
| $5.24M | 0.63% | 4,389,685 +4,235,299 | +2,743% | +$5.05M |
|
|
ECYT
35
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $5.23M | 0.63% | 671,300 +252,585 | +60% | +$1.97M |
|
36
Sonida Senior Living
SNDA
$488M
| $5.01M | 0.6% | 208,753 -405,336 | -66% | -$9.72M |
|
|
INFI
37
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $4.83M | 0.58% | 350,000 +154,845 | +79% | +$2.14M |
|
|
ATHX
38
DELISTED
Athersys, Inc. Common Stock
ATHX
| $4.25M | 0.51% | 1,700,887 -449,230 | -21% | -$1.12M |
|
|
ADYX
39
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $4.04M | 0.49% | +557,491 | New | +$4.04M |
|
|
40
Gilead Sciences
GILD
$140B
| $3.76M | 0.45% | 50,000 -814,070 | -94% | -$61.2M |
|
41
Tandem Diabetes Care
TNDM
$845M
| $3.24M | 0.39% | +125,600 | New | +$3.24M |
|
42
Verastem
VSTM
$569M
| $2.52M | 0.3% | 220,000 -21,065 | -9% | -$241K |
|
|
ISEE
43
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.43M | 0.29% | +75,000 | New | +$2.43M |
|
|
MGCD
44
DELISTED
MGC Diagnostics Corporation
MGCD
| $2.27M | 0.27% | 179,619 +5,170 | +3% | +$65.5K |
|
|
CMRX
45
DELISTED
Chimerix, Inc.
CMRX
| $2.26M | 0.27% | +150,000 | New | +$2.26M |
|
|
ZGNX
46
DELISTED
Zogenix, Inc.
ZGNX
| $2.24M | 0.27% | +650,000 | New | +$2.24M |
|
|
FPRX
47
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.23M | 0.27% | +132,500 | New | +$2.23M |
|
|
AUXL
48
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $2.07M | 0.25% | +100,000 | New | +$2.07M |
|
49
Zimmer Biomet
ZBH
$21B
| $1.86M | 0.22% | +20,000 | New | +$1.86M |
|
|
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.84M | 0.22% | 30,585 -164,116 | -84% | -$9.89M |
|